10 Styczeń 2022
Sofia, Bulgaria, January 10, 2022 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for December 2021 the Company recorded a decrease in sales of 4% compared to the same month of the previous year, incl. 32% decrease in domestic sales and 19% increase in export sales.
For the 2021 the revenues from sales of products decrease by 3% compared to the 2020, incl. 14% increase of sales for the domestic market and 12% decrease in export sales.